Your browser doesn't support javascript.
loading
Can Practical Nurses Identify Older Home Care Clients at Risk of Drug-Related Problems-Geriatricians' Appraisal of Their Risk Screenings: A Pilot Study.
Dimitrow, Maarit; Puustinen, Juha; Viikari, Paula; Puumalainen, Emmi; Vahlberg, Tero; Airaksinen, Marja S A; Kivelä, Sirkka-Liisa.
Afiliación
  • Dimitrow M; University of Helsinki, Helsinki, Finland.
  • Puustinen J; University of Helsinki, Helsinki, Finland.
  • Viikari P; Satakunta Central Hospital, Pori, Finland.
  • Puumalainen E; Turku City Hospital, Turku, Finland.
  • Vahlberg T; University of Helsinki, Helsinki, Finland.
  • Airaksinen MSA; University of Turku, Turku, Finland.
  • Kivelä SL; University of Helsinki, Helsinki, Finland.
J Pharm Technol ; 34(3): 99-108, 2018 Jun.
Article en En | MEDLINE | ID: mdl-34861022
Background: Home care (HC) clients are increasingly older, have many chronic diseases, and use multiple medicines and thus are at high risk for drug-related problems (DRPs). Objective: Establish the sensitivity of practical nurse (PN) administered DRP risk assessment tool (DRP-RAT) compared with geriatrician's assessment of the medical record. Identify the clinically most significant DRPs needing action. Methods: Twenty-six PNs working in HC of Härkätie Health Center in Lieto, Finland, 46 HC clients (≥65 years), and a geriatrician participated in this pilot study. The geriatrician reviewed HC clients' medications using 3 different methods. The reviews were based on the following: (1) the PN's risk screening (ie, PN-completed DRP-RAT) and medication list, (2) health center's medical records, and (3) methods 1 and 2 together. The main outcome was the number of "at-risk patients" (ie, the patient is at risk of clinically significant DRPs) by using each review method. Secondary outcomes were clinically most significant DRP-risk predicting factors identified by the geriatrician. Results: The geriatrician reviewed 45 clients' medications using all 3 methods. Based on PN-completed DRP-RAT and medication list, 93% (42/45) of the clients were classified as "at-risk patients." Two other review methods resulted in 45/45 (100%) "at-risk patients." Symptoms suggestive of adverse drug reactions were the most significant risk predicting factors. Small sample size limits the generalizability of the results. Conclusions: The PN-completed DRP-RAT was able to provide clinically important timely patient information for clinical decision making. DRP-RAT could make it possible to more effectively involve PNs in medication risk management among older HC clients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pharm Technol Año: 2018 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pharm Technol Año: 2018 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos